|
Market Closed -
Deutsche Boerse AG
10:01:53 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 140.40 EUR | -0.43% |
|
-3.54% | -11.31% |
| 10-02 | AbbVie joins US government pilot to test drug discount rebates | RE |
| 10-02 | Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion | DJ |
| Market Cap | 244B 216B 202B 184B 347B 23,456B 350B 2,446B 948B 11,959B 914B 895B 38,436B | P/E 2026 * |
20x | P/E 2027 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 263B 234B 218B 199B 375B 25,353B 379B 2,644B 1,025B 12,926B 988B 967B 41,544B | EV / Sales 2026 * |
4.17x | EV / Sales 2027 * | 3.81x |
| Free-Float |
96.62% | Yield 2026 * |
2.13% | Yield 2027 * | 2.26% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AZN | Delayed | |
NYSE
| AZN | End-of-day quote | |
|
Nasdaq Stockholm
| AZN | Delayed | |
|
CBOE
| AZN | Real-time | |
|
CBOE
| AZNs | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Tradegate
| ZEG | Real-time | |
|
Mexican S.E.
| AZN1 N | End-of-day quote | |
|
Deutsche Boerse AG
| ZEG | Delayed | |
|
Boerse Muenchen
| ZEG | Real-time | |
|
Börse Stuttgart
| ZEG | Delayed | |
|
CBOE
| AZN | Real-time | |
|
Berne S.E.
| 000982352 | End-of-day quote |
Last Transcript: AstraZeneca PLC
| 1 day | -0.43% | ||
| 1 week | -3.54% | ||
| Current month | -2.06% | ||
| 1 month | -1.02% | ||
| 3 months | -17.17% | ||
| 6 months | -20.48% | ||
| Current year | -11.31% |
| 1 week | 140 |  | 148.95 |
| 1 month | 134.6 | | 148.95 |
| Current year | 134 | | 180.45 |
| 1 year | 134 | | 180.45 |
| 3 years | 112.45 | | 180.45 |
| 5 years | 95.48 | | 180.45 |
| 10 years | 47.74 | | 180.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Jeffrey Pott
CMP | Compliance Officer | - | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.43% | -3.54% | - | - | 244B | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -0.73% | -3.39% | +26.07% | +58.90% | 410.8B | |
| Weighted average by Cap. | -0.59% | -3.33% | +29.07% | +71.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.17B 56.11B 52.32B 47.69B 90.02B 6,083B 90.82B 634B 246B 3,102B 237B 232B 9,969B | 67.01B 59.52B 55.5B 50.58B 95.49B 6,453B 96.34B 673B 261B 3,290B 252B 246B 10,574B |
| Net income | 12.04B 10.7B 9.97B 9.09B 17.16B 1,160B 17.32B 121B 46.89B 591B 45.21B 44.23B 1,900B | 13.77B 12.23B 11.41B 10.4B 19.63B 1,326B 19.8B 138B 53.63B 676B 51.71B 50.59B 2,173B |
| Net Debt | 19.69B 17.49B 16.31B 14.87B 28.07B 1,897B 28.31B 198B 76.68B 967B 73.94B 72.33B 3,108B | 11.93B 10.6B 9.88B 9.01B 17B 1,149B 17.15B 120B 46.46B 586B 44.79B 43.82B 1,883B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | €140.40 | -0.43% | 687 |
| 26-10-01 | €141.00 | -1.64% | 325 |
| 26-09-30 | €143.35 | -1.48% | 634 |
| 26-09-29 | €145.50 | -1.89% | 1,843 |
| 26-09-28 | €148.30 | +1.89% | 1,181 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- ZEG Stock
Select your edition
All financial news and data tailored to specific country editions
